SCHEMBL8096612

SCHEMBL8096612

CC(C)CCN(C)C(C)(C)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.42
TTR P02766 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.40
KCNN4 O15554 1/20 0.38
HTR2A P28223 3/20 0.37
HRH1 P35367 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AOC3 Q16853 2/20 0.36
LMNA P02545 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
RIPK1 Q13546 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23374742 0.85 CYP2D6 (0.46) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL13061198 0.79 SMN1; SMN2 (0.48) CYP2D6ALDH1A1CYP2C19KCNN4HTR2A
SCHEMBL12566248 0.79 KDM4E (0.47) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL8084282 0.76 TAAR1 (0.55) AOC3TAAR1
SCHEMBL12478391 0.74 SIGMAR1 (0.41) CYP2D6ALDH1A1MEN1KMT2AKCNN4
SCHEMBL12610396 0.74 CHRM2 (0.38) CYP2D6ALDH1A1CYP2C19MEN1KMT2A
SCHEMBL23423652 0.74 KCNN4 (0.44) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL8097390 0.73 AOC3 (0.55) AOC3OPRM1TAAR1DRD3
SCHEMBL20844607 0.72 TAAR1 (0.50) CYP2D6ALDH1A1CYP2C19HSD17B10KMT2A
SCHEMBL8100038 0.71 SIGMAR1 (0.58) AOC3OPRM1TAAR1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed